We speculate that the deregulated signalling pathways in prostate cancer cells, including aberrant control of cell cycle progression and death, compensate for many of the E1A-functions that are required for sensitization in normal or transformed cells. This evidence concerns the gene DHTKD1 and prostate carcinoma.